165,000 dementia patients reveal hidden stroke risk from common drug

A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic increases stroke risk in dementia patients across the board—including those with no prior heart disease or stroke—challenging the long-held belief that some patients might be safer candidates than others. Because risperidone is the only drug of its type licensed for dementia, doctors often use it as a last resort when distressing symptoms become unmanageable.
MoMath Brings Prime Numbers to a Prime New Location
After outgrowing its original home, the National Museum of Mathematics has added new exhib…









